Clinical Trial Update: Disrupting the Bone Marrow Microenvironment With G-CSF in Acute Lymphoblastic Leukemia [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial investigates using granulocyte colony-stimulating factor (G-CSF) to disrupt the bone marrow microenvironment in acute lymphoblastic leukemi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• G-CSF (granulocyte colony-stimulating factor)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Precursor Cell Lymphoblastic Leukemia-Lymphoma | EARLY_Phase 1 | Status: COMPLETED